Wageningen UR-ko ikertzaileekin lankidetzan egindako argitalpenak (9)

2016

  1. Interindividual variation in gene expression responses and metabolite formation in acetaminophen-exposed primary human hepatocytes

    Archives of Toxicology, Vol. 90, Núm. 5, pp. 1103-1115

2015

  1. Integrating multiple omics to unravel mechanisms of Cyclosporin A induced hepatotoxicity in vitro

    Toxicology in Vitro, Vol. 29, Núm. 3, pp. 489-501

2013

  1. Identification of Cisplatin-Regulated Metabolic Pathways in Pluripotent Stem Cells

    PLoS ONE, Vol. 8, Núm. 10

2012

  1. 'Omics analysis of low dose acetaminophen intake demonstrates novel response pathways in humans

    Toxicology and Applied Pharmacology, Vol. 259, Núm. 3, pp. 320-328

  2. Application of an untargeted metabolomics approach for the identification of compounds that may be responsible for observed differential effects in chickens fed an organic and a conventional diet

    Food Additives and Contaminants - Part A Chemistry, Analysis, Control, Exposure and Risk Assessment, Vol. 29, Núm. 3, pp. 323-332

  3. Use of NMR metabolomic plasma profiling methodologies to identify illicit growth-promoting administrations

    Analytical and Bioanalytical Chemistry, Vol. 403, Núm. 2, pp. 573-582

2011

  1. An untargeted multi-technique metabolomics approach to studying intracellular metabolites of HepG2 cells exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin

    BMC Genomics, Vol. 12

  2. Integrating transcriptomics and metabonomics to unravel modes-of-action of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in HepG2 cells

    BMC Systems Biology, Vol. 5

  3. Ultra-fast searching assists in evaluating sub-ppm mass accuracy enhancement in U-HPLC/Orbitrap MS data

    Metabolomics, Vol. 7, Núm. 1, pp. 15-24